@ARTICLE{
author={Xu B,...,Kostic S,...,Milenkovic D,...,(broj koautora 21)},
year={2026},
title={OPTIMAL: a multinational phase III study of oral paclitaxel (DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer},
journal={ANNALS OF ONCOLOGY},
volume={37},
number={7},
pages={936-945},
document_type={Article},
}